Gland Pharma Limited
GLAND
Quarterly results
Revenue and net profit
₹ crore
Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.
- Income
- ₹ crore
Jun 20261,287
Quarter ₹ crore YoY Jun 2024 1,012 +14.5% Sept 2024 1,063 +5.2% Dec 2024 1,011 -7.9% Mar 2025 1,030 -12.3% Jun 2025 1,039 +2.6% Sept 2025 1,074 +1.1% Dec 2025 1,178 +16.5% Mar 2026 1,262 +22.4% Jun 2026 1,287 +23.9% - ₹ crore
Jun 202659
Quarter ₹ crore Jun 2024 48 Sept 2024 58 Dec 2024 65 Mar 2025 44 Jun 2025 55 Sept 2025 83 Dec 2025 60 Mar 2026 106 Jun 2026 59 - ₹ crore
Jun 20261,345
Quarter ₹ crore Jun 2024 1,061 Sept 2024 1,121 Dec 2024 1,076 Mar 2025 1,074 Jun 2025 1,094 Sept 2025 1,157 Dec 2025 1,238 Mar 2026 1,368 Jun 2026 1,345 - Cost structure
- ₹ crore
Jun 2026144
Quarter ₹ crore Jun 2024 108 Sept 2024 106 Dec 2024 105 Mar 2025 120 Jun 2025 128 Sept 2025 132 Dec 2025 134 Mar 2026 134 Jun 2026 144 - ₹ crore
Jun 2026858
Quarter ₹ crore Jun 2024 760 Sept 2024 741 Dec 2024 682 Mar 2025 683 Jun 2025 731 Sept 2025 748 Dec 2025 801 Mar 2026 803 Jun 2026 858 - Exceptional items and tax
- ₹ crore
Jun 2026488
Quarter ₹ crore Jun 2024 300 Sept 2024 380 Dec 2024 394 Mar 2025 391 Jun 2025 362 Sept 2025 409 Dec 2025 412 Mar 2026 565 Jun 2026 488 - ₹ crore
Jun 2026123
Quarter ₹ crore Jun 2024 77 Sept 2024 98 Dec 2024 99 Mar 2025 101 Jun 2025 93 Sept 2025 107 Dec 2025 105 Mar 2026 144 Jun 2026 123 - Profit
- ₹ crore
Jun 2026364
Quarter ₹ crore YoY Jun 2024 223 +18.8% Sept 2024 282 +9.4% Dec 2024 295 +6.6% Mar 2025 290 -9.8% Jun 2025 269 +20.8% Sept 2025 302 +7.2% Dec 2025 308 +4.3% Mar 2026 420 +45.0% Jun 2026 364 +35.3% - Per share
- ₹ per share
Jun 202622.11
Quarter ₹ per share Jun 2024 13.53 Sept 2024 17.10 Dec 2024 17.91 Mar 2025 17.60 Jun 2025 16.34 Sept 2025 18.33 Dec 2025 18.68 Mar 2026 25.52 Jun 2026 22.11
| ₹ crore | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Income | |||||||||
| 1,012 | 1,063 | 1,011 | 1,030 | 1,039 | 1,074 | 1,178 | 1,262 | 1,287 | |
| Revenue YoY | +14.5% | +5.2% | -7.9% | -12.3% | +2.6% | +1.1% | +16.5% | +22.4% | +23.9% |
| 48 | 58 | 65 | 44 | 55 | 83 | 60 | 106 | 59 | |
| 1,061 | 1,121 | 1,076 | 1,074 | 1,094 | 1,157 | 1,238 | 1,368 | 1,345 | |
| Cost structure | |||||||||
| 108 | 106 | 105 | 120 | 128 | 132 | 134 | 134 | 144 | |
| 760 | 741 | 682 | 683 | 731 | 748 | 801 | 803 | 858 | |
| Exceptional items and tax | |||||||||
| 300 | 380 | 394 | 391 | 362 | 409 | 412 | 565 | 488 | |
| 77 | 98 | 99 | 101 | 93 | 107 | 105 | 144 | 123 | |
| Profit | |||||||||
| 223 | 282 | 295 | 290 | 269 | 302 | 308 | 420 | 364 | |
| Net profit YoY | +18.8% | +9.4% | +6.6% | -9.8% | +20.8% | +7.2% | +4.3% | +45.0% | +35.3% |
| Per share | |||||||||
| 13.53 | 17.10 | 17.91 | 17.60 | 16.34 | 18.33 | 18.68 | 25.52 | 22.11 | |
Latest filed period ends Jun 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.